Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 6731
116th Congress(2019-2020)
Securing America’s Pharmaceutical Supply Chain Act
Introduced
Introduced
Introduced in House on May 5, 2020
Overview
Text
Introduced
May 5, 2020
Latest Action
May 5, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6731
Congress
116
Policy Area
Government Operations and Politics
Government Operations and Politics
Primary focus of measure is government administration, including agency organization, contracting, facilities and property, information management and services; rulemaking and administrative law; elections and political activities; government employees and officials; Presidents; ethics and public participation; postal service. Measures concerning agency appropriations and the budget process may fall under Economics and Public Finance policy area.
Sponsorship by Party
Republican
Pete Stauber
Minnesota
Democrat
John Garamendi
California
Republican
Jim Hagedorn
Minnesota
Republican
Bob Gibbs
Ohio
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Securing America's Pharmaceutical Supply Chain Act

This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.

This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.

The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.

Text (1)
Introduced in House
May 5, 2020
Actions (2)
05/05/2020
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/05/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:43:00 PM
Copyright © 2024 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About